Background. In England and Wales, the incidence of invasive meningococcal disease has been declining for more than a decade, but meningococcal group W (MenW) cases have been increasing since 2009.
Neisseria meningitidis is a major infectious cause of morbidity and mortality worldwide [1] . In the United Kingdom, routine vaccination against meningococcal capsular group C (MenC) since 1999 has resulted in capsular group B (MenB) being responsible for >85% of invasive meningococcal disease (IMD) cases across all age groups [2] . The meningococcal quadrivalent conjugate vaccine (MenACWY) is only used for highrisk individuals and travelers to endemic regions and for controlling outbreaks. Recently, much attention has been focused on MenB prevention following the licensure of a novel, protein-based, multicomponent vaccine in Europe [3] . At present, however, England and Wales are experiencing an upsurge in invasive capsular group W (MenW) disease. Historically, MenW incidence has been low, accounting for only 1%-2% of IMD cases annually. An increase during 2000-2002 was associated with travel to the Hajj [4] , but following mandatory meningococcal vaccination for pilgrims, MenW cases declined to pre-2000 levels. Since 2009-2010, however, MenW cases have increased year-on-year. In response to this increase, we followed up all laboratory-confirmed MenW cases diagnosed over 3 epidemiological years and investigated the genomic profile of clinical MenW isolates over the same time period by using publicly available whole-genome sequencing data. This study describes the epidemiology of invasive MenW disease in England and Wales since [2000] [2001] , clinical characteristics of case-patients with laboratory-confirmed MenW disease during 2010-2011 to 2012-2013, and the molecular characteristics of clinical MenW isolates. In particular, the study aimed to identify differences in risk factors, clinical characteristics, or outcomes of IMD caused by the emerging MenW strain compared with previously circulating strains.
METHODS
Public Health England (PHE) routinely conducts national surveillance of IMD using a combination of clinical and laboratory reporting schemes [5] . At the same time, PHE's Meningococcal Reference Unit (MRU) provides a national service for species confirmation, grouping, typing, subtyping, and antimicrobial susceptibility testing of all invasive Neisseria meningitidis isolates. The MRU also provides free nonculture polymerase chain reaction (PCR) confirmation of meningococcal diagnosis (including genogroup and genosubtype analysis) for clinical specimens that are routinely submitted by National Health Service (NHS) hospitals in England and Wales [5] .
From 2012, after the observed increase in MenW cases, laboratory-confirmed (culture and/or PCR) MenW cases diagnosed in England and Wales were identified retrospectively and prospectively and followed up for 3 epidemiological years (July 2010 to June 2013) by requesting that the case-patient's general practitioner or, alternatively, the hospital physician or public health consultant complete a short questionnaire. Case-patients reported to have died were cross-checked with the national electronic Personal Demographic Service database (http://www.connectingforhealth.nhs.uk/systemsandservices/ demographics/pds), and the cause of death was ascertained from death registration records provided to PHE by the Office for National Statistics (www.statistics.gov.uk). Genomic data for all English and Welsh MenW isolates collected over the corresponding 3-year period were obtained from the Meningitis Research Foundation Meningococcus Genome Library (www.meningitis.org/genome-library). The population structure of the MenW sequence type (ST) 11 clonal complex (cc11) isolates was characterized at high resolution by performing a partial meningococcal genome comparison using the genome comparator tool in www.pubmlst.org. In brief, the isolates were compared in terms of a total of 1546 of 1592 core genes employing a "gene by gene" approach that uses arbitrary, sequentially assigned, preindexed allele identifiers at each gene, akin to those of standard 7-locus multilocus sequence typing [6] . A Neighbor-net phylogenetic network was then generated by applying SplitsTree4 (version 4.12.8) to the resulting distance matrix [7] . The remaining 46 core genes were excluded from the analysis, having previously generated false differences due to paralogy (eg, the Elongation Factor Tu genes neis0116 and neis0128) or the presence of hypermutable homopolymeric tracts (eg, the phase variable lacto-N-neotetraose biosynthesis glycosyl transferase gene, lgtA, or neis1902). The included/excluded loci are listed in Supplementary Clinical information was collected for all 129 laboratoryconfirmed MenW cases during the 3 epidemiological years. A quarter of cases occurred in children aged <5 years, and half the cases in adults aged ≥45 years. The demographics, clinical characteristics, risk factors, infecting strain, and outcome by infecting strain are summarized in Supplementary Table 2 . Of note, only 2 case patients had a history of travel-both were overseas residents visiting the United Kingdom when they ) were uncommon, mainly malignancy and chronic renal disease, respectively, and occurred mostly in those aged ≥65 years. None had asplenia, splenic deficiency, or previously known complement deficiency. Half of the case-patients presented with septicemia, which was relatively consistent across the age groups. Bacteremic pneumonia (10 cc11, 5 non-cc11) was more common in those aged ≥45 years (13/65 [20%] vs 2/64 [3%] in those aged <45 years; P = .003). Of note, 9 case-patients developed septic arthritis with MenW isolated from joint fluid (4 cc11, 3 non-cc11, 2 unknown), mainly at extremes of age. In addition, 5 cases presented with severe upper respiratory tract infection (epiglottitis or supraglottitis; 3 cc11, 1 non-cc11, 1 unknown). Overall, intensive care admission was high (37%), especially in older children and young adults. Two-thirds of those with meningitis and septicemia required intensive care unit (ICU) admission (14/21 [67%]), 56% with meningitis (9/16), 40% pneumonia (6/15), and 30% septicemia (19/63). In total, 19 patients died and 15 deaths were meningococcal-related (case-fatality ratio [CFR], 13%), with nearly all deaths occurring within 72 hours of diagnosis (13/15 [87%]). The 4 nonmeningococcal deaths occurred in adults aged ≥65 years who recovered from their infection but died ≥6 weeks later. CFR was similar for all clinical presentations apart from those with severe upper respiratory tract infection (none required intensive care or died).
There was no association between the infecting strain (cc11 vs non-cc11 vs not typed or type 2a vs nontypeable vs not typed) and age at disease, risk factors, clinical presentation, ICU admission, or case fatality. However, 14 of the 19 deaths among cases with typed isolates during 2010-2011 to 2012-2013 were associated with MenW:cc11. In contrast to noncc11 strains, which were only fatal in older adults, MenW:2a was also associated with death in children and young adults.
DISCUSSION
The increase in invasive MenW disease in England and Wales since 2009-2010 is almost entirely due to endemic expansion of a single clone belonging to cc11 and, although the number of cases remains low nationally, this expansion appears to be continuing, with no evidence of plateauing after 5 years. In 2013-2014, most of the MenW isolates that underwent molecular typing belonged to the 2a phenotype, and it is likely that this strain contributes to a similar high proportion of the untyped, PCR-positive cases. Genomic analysis of MenW isolates over 3 epidemiological years confirmed all PorB 2a isolates as belonging to cc11, in addition to 7 of the PorB nontypeable isolates. PorA P1.5,2 has also proved to be an imperfect marker for MenW:cc11 isolates, thus highlighting the usefulness of extended sequence analyses over serological characterization.
The emergence of cc11 cases occurred initially in adults but soon extended across all age groups such that, by 2013-2014, cc11 accounted for nearly all MenW cases in individuals aged 5-64 years and two-thirds of cases in those aged <5 and ≥65 years. Although there were no discernible differences in age distribution, clinical characteristics, or outcome in disease caused by cc11 strains compared with other strains or PCR-positive cases, the continuing increase in overall MenW cases is concerning. Unlike previously observed temporary increases in meningococcal group Y disease, for example, which occurred primarily in older adults with underlying comorbidities [8] , the MenW cases have occurred mainly in healthy individuals of all ages, who developed severe clinical disease often requiring intensive care support. Moreover, the clinical presentation in a significant proportion of MenW cases was not typical of meningococcal disease, with septic arthritis and severe respiratory tract infections being overrepresented. Such atypical presentations have previously been reported in MenW case-patients [9] . Among 119 pediatric MenW cases diagnosed in France during 2001-2008, for example, 10 (8%) presented with septic arthritis [10] . Similarly, an older US study also reported a higher prevalence of arthritis with MenW (3.3%) than MenB (0.6%) or MenC (1.1%) disease [11] . Meningococcal epiglottitis and supraglottitis are even rarer presentations of meningococcal disease and, to our knowledge, have never been reported for MenW infections [12] . With such unusual presentations, IMD would not be suspected until the pathogen is isolated from routine culturing of blood, joint fluid, or another sterile site. Indeed, in the absence of clinical suspicion, culture-negative samples might not be sent for PCR testing, which may explain the overrepresentation of MenW culture confirmations, especially among older age groups. This could lead to potential delays in providing chemoprophylaxis to close contacts to prevent secondary cases [13] .
The MenW-associated CFR in our cohort (12%) was not as high as the 20% reported during the Hajj-associated outbreaks [4, 14] . It has been postulated that cc11 is more virulent and this is why it was associated with higher CFR for the Hajj-associated MenW (20%) compared with other culture-confirmed meningococcal disease during 1995-2000 (9%; risk ratio [RR], 2.0; 95% confidence interval [CI], 1.3-3.1) or other MenW serotypes (9%; RR, 2.6; 95% CI, 1.4-4.8), but similar to the CFR for culture-confirmed MenC:2a cases, also associated with cc11 (15%; RR, 1.3; 95% CI, .8-2.1) [4] . We did not observe any difference in CFR among cases caused by MenW:2a and other meningococcal strains. However the recent increase in MenW:2a cases has led to more MenW-associated deaths attributed to this strain and, more concerningly, MenW-related deaths were, for the first time in the past decade, observed in children and young adults.
Unlike the international MenW outbreak following Hajj pilgrimages in 2000 and 2001 [4] , our follow-up of cases did not identify any association with travel or recent entry into the United Kingdom, nor was there any evidence of clustering of cases within households. A number of countries in Latin America, Africa, and eastern Asia have already reported increases in endemic MenW disease caused by strains belonging to cc11. In Brazil, MenW was uncommon until 2003, when MenW:cc11 emerged and started causing sporadic cases, outbreaks, and field clusters [15, 16] . A similar increase in MenW cases has been reported in Argentina since 2008, where, like Brazil, most reported cases were diagnosed in young children [17] . In Chile, MenW:2a belonging to cc11 emerged at the end of 2011 and, during 2012, 58% of laboratory-confirmed cases were caused by MenW, with 47% of cases occurring in children <5 years [18] . This increase was also associated with higher case fatality for IMD cases at all ages, from 15% in 2011 to 21% in 2012.
In South Africa, MenW incidence in Gauteng province increased across all age groups from 0.06 per 100 000 in 2000 to 2.99 per 100 000 in 2005, but particularly among infants [14] . When compared to other capsular groups, MenW was more likely to affect children aged <5 years, to cause septicemia rather than meningitis, and to result in a fatal outcome [14] . The responsible MenW isolates were highly clonal (ST-11/ET-37 complex, [W]ET-37 clone) and indistinguishable from the Hajj-related outbreak isolates.
In sub-Saharan Africa, the Hajj-associated MenW strain caused epidemics in several countries across the meningitis belt during the early 2000s [14] . In 2012, cases of MenW belonging to cc11 reemerged, 2 years after the mass vaccination program with a meningococcal group A (MenA) conjugate vaccine [19] . In Burkina Faso, for example, a total of 5807 meningitis cases were reported through enhanced surveillance in 2012, of which 2353 (41%) were laboratory confirmed. MenW accounted for 62%, and all 61 isolates that were characterized belonged to cc11. The predominant strain was P1.5,2: F1-1: ST-11 (cc11), which accounted for 90% (55/61) of isolates, and was the same finetype as that of the 2002 Burkina Faso epidemic strain. Other sub-Saharan countries have similarly reported an increase in MenW disease, also in young children, following the successful implementation of the MenA conjugate vaccine [20, 21] . A small but significant increase in cc11 MenW has also been reported in southeastern China during 2011-2012, where a comparable MenW strain was isolated from patients, their close contacts, and healthy carriers, suggesting possible establishment and local spread of this particular strain.
With such high volumes of international travel, it is not surprising that some countries have observed an increase in travelassociated MenW infections. In France, for example, half of the 16 MenW cases diagnosed during January-April 2012 (compared with <5 annual cases previously) could be linked with travel to, or contact with someone who had traveled to, subSaharan Africa during the MenW epidemic [22] . The 8 imported cases were caused by MenW:2a strains of the finetype P1.5,2: F1-1:ST-11 (cc11), the same as that observed among cases from Cote d'Ivoire [23] .
Other than the United Kingdom, as far as we are aware, no other European country has yet reported a recent increase in endemic MenW disease. The core genome comparison among MenW:cc11 isolates causing IMD in England and Wales has afforded unprecedented resolution of what normally appears to be a single clone using conventional multilocus sequence typing. The tight clustering (mean distance of 33 loci) of the majority of the recent English and Welsh MenW:cc11 isolates is consistent with this being a relatively rapid clonal expansion. By comparison, the mean distance among the relatively stable and endemic cc22 (n = 32) isolates over this time period was 185 loci (SD, 87 loci) (data not presented). The only isolate belonging to the relatively rare, historical cluster was obtained from a toddler of black African ethnicity, who had never traveled outside England, although this does not preclude recent import and subsequent transmission. It is tempting to speculate that this cluster (also containing historical isolates from South Africa, Burkina Faso, and England) represents that of the so-called Hajj outbreak strain-indeed, the corresponding English/Welsh case from 2001 involved a recently returned pilgrim. Nonetheless, the small number of fully characterized isolates from this period and the apparent complexity of the MenW:cc11 population structure highlight the need for more detailed characterization of geographically and temporally diverse MenW:cc11 isolates to fully reconcile past and current episodes of increased MenW:cc11 cases.
The emergence and rapid clonal expansion with continuing increase in endemic MenW:cc11 disease in the United Kingdom will require close monitoring in the coming years, particularly given that natural immunity against this capsular group is low across all age groups [24] . MenW is potentially preventable through vaccination with the quadrivalent MenACWY conjugate vaccine [25] , and if the trend continues to establish itself in children and young adults (as it has done in South Africa, Latin America, and other regions), then it may be prudent to consider supplementing the current MenC conjugate vaccine program with the quadrivalent conjugate vaccine. Vaccination of an age group with high MenW carriage, if such a group could be identified, could also potentially prevent overall cases through indirect (herd) protection.
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